Editorial
Low-dose aspirin for primary cardiovascular prevention in diabetic patients: the issue to believe it or not
Abstract
Primary prevention is addressed to forestall the outbreak of cardiovascular disease by facing its natural causes and risk factors. At a different level, secondary prevention involves strategies and therapies targeting preclinical or clinical verification of cardiovascular disease development.
